RxDoctor Payments Data

Katherine Pederson, DO

Family Medicine · Mansfield, TXNPI 1902218852

Payments from drug & device makers

$12,703in general payments, 2019–2025

Across 177 payments — averaging $71.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$9K
  • Merck$1K
  • Novo Nordisk$354
  • AstraZeneca$320
  • Lilly USA, LLC$306
  • Amarin Pharma, Inc.$253
  • plus $2K from 25 others

What the payments were for

  • Speaking & faculty fees$9,81777%
  • Food & beverage$2,88623%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,703 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$38,463
Medicare patients
92
Services billed
512

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$23,708
TrulicityDulaglutide11$14,226
JardianceEmpagliflozin13$11,273
LantusInsulin Glargine,hum.Rec.Anlog11$1,849
Levothyroxine Sodium104$966
Albuterol Sulfate HfaAlbuterol Sulfate33$870
Atorvastatin Calcium74$725
Nebivolol Hcl12$637
Montelukast Sodium42$576
Rosuvastatin Calcium66$552
Celecoxib16$518
Pantoprazole Sodium32$440
Metoprolol Succinate30$414
Escitalopram Oxalate39$412
Bupropion XlBupropion Hcl16$386

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$354$23,70818 claims
Lilly USA, LLCTrulicity$306$14,22611 claims
Boehringer IngelheimJardiance$172$11,27313 claims
Sanofi-aventis U.S. LLCLantus$132$1,84911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Mansfield

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →